While developing appropriate laws to serve Switzerland, we can learn from and build on current EU experiences of how GDPR affects clinical research.
Exploring the broader EU setting
How will the new European data protection regulation affect clinical research? And what recommendations can be derived, to make it run more smoothly? These questions, among others, were addressed in a recently published article by Demotes-Mainard, Cornu, and Guérin (Therapie. 2019 February; 74(1), 31-42). It was published originally in French and translated into English.
The article is an outcome of a roundtable held in 2018 with French representatives from the European Clinical Research Infrastructure Network (ECRIN), clinical scientists from university hospitals and public research organisations, the industry, and authorities, on the topic of data protection. The objectives were to identify problematic areas, including those in the need for clarification, and to make related recommendations to promote clinical research, while ensuring a high level of patient protection. The authors outlined comprehensively all stages of clinical research affected by GDPR (see Table 1, reproduced with permission).
0 Comments
Add a new comment